NL-OMON34378撤回不适用
A Prospective, randomized , placebo, controlled trial ( double blinded) to assess the potential role of vitamin D treatment in breast cancer patients - Potential role of Vitamin D treatment in Breast Cancer
适应症
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 入组人数
- 110
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •primary operable invasive breast cancer
排除标准
- •Previously clinically detected nefrolithiasis (on diagnostic imaging techniques).
- •Previously clinically detected cholelithiasis (on diagnostic imaging techniques).
- •History of sarcoidosis.
- •History of recurrent urolithiasis.
- •Already taking Vitamin D (colecalciferol) supplement >400 IU/day.
- •Calcium-lowering therapy within 2 weeks before study entry.
- •Previously documented impaired renal function.
研究者
相似试验
进行中（未招募）
1 期
A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin(R) in acute ischemic hemispehric stroke - CERE-LYSE-1EUCTR2004-001729-11-SKEBEWE Pharma GesmbH Nfg.KG
进行中（未招募）
不适用
A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke - CERE-LYSE-1Clinical diagnosis of ischemic stroke causing a measurable neurological deficitdefined as impairment of language, motor function, cognition and/or gaze,vision or neglect. Ischemic stroke is defined as an event characterised by thesudden onset of an acute focal neurologic deficit presumed to be due tocerebral ischemia after CT scan excludes haemorrhage. Onset of symptoms within 3 hours prior to initiation of rt-PA administrationMedDRA version: 6.0Level: LLTClassification code 10055221EUCTR2004-001729-11-SIEBEWE Pharma Ges.m.b.H Nfg.KG108
进行中（未招募）
1 期
A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin(R) in acute ischemic hemispehric stroke - CERE-LYSE-1EUCTR2004-001729-11-CZEBEWE Pharma GesmbH Nfg.KG
进行中（未招募）
不适用
A prospective, randomised, placebo controlled, double blind trial about safety and efficacy of combined treatment with Alteplase (rt-PA) and Cerebrolysin in acute ischemic hemispheric stroke - CERE-LYSE-1EUCTR2004-001729-11-ATEBEWE Pharma Ges.m.b.H Nfg.KG108
尚未招募
4 期
Prospective, randomized, placebo controlled trial to evaluate the efficacy of transcutaneous stimulation of n. tibialis posterior in treatment of idiopathic overactive bladderN39.42N31.82DRKS00021250niversitätsklinikum Münster116